The phrase "a wide range of subgroups" is correct and usable in written English.
It can be used when discussing diversity or variety within a larger group, particularly in contexts like research, sociology, or organizational structures.
Example: "The study revealed a wide range of subgroups within the population, each with distinct characteristics and needs."
Alternatives: "a broad spectrum of subgroups" or "a diverse array of subgroups."
Exploratory objectives included an analysis of sarilumab efficacy in a wide range of population subgroups to test the robustness of the therapeutic activity of the drug.
This was found across a wide range of patient subgroups, different cardiovascular outcomes, different assumptions about exposure, and different utilization patterns.
We therefore used regression models to estimate the costs, QALY gains and cost-effectiveness of TKR in a wide range of patient subgroups while controlling for multiple baseline characteristics.
Numerous clinical trials have shown that pitavastatin is well tolerated and beneficially modifies the lipid profile with a similar or greater efficacy to equivalent doses of atorvastatin, rosuvastatin, simvastatin and pravastatin in a wide range of patient subgroups [ 20- 30], including those with MetS or T2D [ 23, 24, 31].
Additionally, it comprehensively records a wide range of clinically relevant subgroups to carry out the most detailed exploration of potential heterogeneity than previously reported.
There is a wide range of 12 different diagnostic subgroups.
In principle, health technology assessment allows a consideration of all the costs and benefits of innovative drugs in a wide range of indications and patient subgroups.
To explore the difference between non-malignant reference tissue and neoplastic cells, we further investigated the methylation status of SOX11 in 42 cell lines (Table 1) representing a wide range of human tumors with subgroups known to express SOX11, including lymphoid malignancies (n=19), ovarian cancer (n=5), breast cancer (n=8), lung cancer (n=3), brain cancers (n=5) and neuroblastoma (n=2).
Table 2 quantifies the positive predictive value for statistically significant subgroup findings (that is, treatment subgroup interaction effects) over a wide range of prior probabilities and number of subgroup comparisons.
Decision tree methodology successfully categorized participants in the PATH cohort into a wide range of depression risk groups, distinguishing subgroups of participants with virtually no risk through to groups with almost 40% risk of having major depressive disorder four years after their status on a raft of risk indicators was ascertained.
